192 related articles for article (PubMed ID: 36617671)
1. Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose.
Kühn T; Speer C; Morath C; Bartenschlager M; Kim H; Beimler J; Buylaert M; Nusshag C; Kälble F; Reineke M; Töllner M; Klein K; Blank A; Parthé S; Schnitzler P; Zeier M; Süsal C; Bartenschlager R; Tran TH; Schaier M; Benning L
Transplantation; 2023 May; 107(5):1139-1150. PubMed ID: 36617671
[TBL] [Abstract][Full Text] [Related]
2. Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination.
Al Jurdi A; Gassen RB; Borges TJ; Solhjou Z; Hullekes FE; Lape IT; Efe O; Alghamdi A; Patel P; Choi JY; Mohammed MT; Bohan B; Pattanayak V; Rosales I; Cravedi P; Kotton CN; Azzi JR; Riella LV
Front Immunol; 2022; 13():838985. PubMed ID: 35281011
[TBL] [Abstract][Full Text] [Related]
3. Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients.
Zhang L; Yang J; Lai C; Wan L; Xiong S; Kong W; Liu Z; Yu P; Chen M; Mai W; Khan SA; Deng M; Chen L; Lei Y; Zhou Q; Yu N; Li P; Chen Z; Ji T
Front Immunol; 2022; 13():1042784. PubMed ID: 36700230
[TBL] [Abstract][Full Text] [Related]
4. Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid.
Benning L; Morath C; Kühn T; Bartenschlager M; Kim H; Beimler J; Buylaert M; Nusshag C; Kälble F; Reineke M; Töllner M; Schaier M; Klein K; Blank A; Schnitzler P; Zeier M; Süsal C; Bartenschlager R; Tran TH; Speer C
Front Med (Lausanne); 2022; 9():958293. PubMed ID: 36059830
[TBL] [Abstract][Full Text] [Related]
5. Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need.
Cheng Y-L; Chang S-S; Chao C-H; Chen P-T; Lin Y-L; Syu G-D; Lee N-Y; Chen P-L; Ko W-C; Ho T-S
Microbiol Spectr; 2024 Jun; 12(6):e0000424. PubMed ID: 38747636
[TBL] [Abstract][Full Text] [Related]
6. Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients.
Takai S; Nishida H; Ito H; Fukuhara H; Nawano T; Narisawa T; Kanno H; Yagi M; Yamagishi A; Sakurai T; Naito S; Kato T; Morikane K; Tsuchiya N
Front Immunol; 2022; 13():1050211. PubMed ID: 36532067
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Drug Monitoring of Mycophenolic Acid Identifies Kidney Transplant Recipients Responsive to Two SARS-CoV-2 mRNA Vaccine Doses.
von Moos S; Rho E; Dammann M; Kokkonen SM; Mueller TF; Schachtner T
Transpl Int; 2023; 36():11286. PubMed ID: 37448450
[TBL] [Abstract][Full Text] [Related]
8. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.
Kho MML; Messchendorp AL; Frölke SC; Imhof C; Koomen VJ; Malahe SRK; Vart P; Geers D; de Vries RD; GeurtsvanKessel CH; Baan CC; van der Molen RG; Diavatopoulos DA; Remmerswaal EBM; van Baarle D; van Binnendijk R; den Hartog G; de Vries APJ; Gansevoort RT; Bemelman FJ; Reinders MEJ; Sanders JF; Hilbrands LB;
Lancet Infect Dis; 2023 Mar; 23(3):307-319. PubMed ID: 36354032
[TBL] [Abstract][Full Text] [Related]
9. A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS-CoV-2 mRNA vaccine.
Borgogna C; Ferrante D; Rosso G; Guglielmetti G; Lo Cigno I; Raviola S; Caneparo V; Quaglia M; Cantaluppi V; Gariglio M
J Med Virol; 2024 Jun; 96(6):e29710. PubMed ID: 38804187
[TBL] [Abstract][Full Text] [Related]
10. Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Sanders JF; Messchendorp AL; de Vries RD; Baan CC; van Baarle D; van Binnendijk R; Diavatopoulos DA; Geers D; Schmitz KS; GeurtsvanKessel CH; den Hartog G; Kho MML; Koopmans MPG; van der Molen RG; Remmerswaal EBM; Rots N; Gansevoort RT; Bemelman FJ; Hilbrands LB; Reinders MEJ;
Clin Infect Dis; 2023 Feb; 76(3):e188-e199. PubMed ID: 35796536
[TBL] [Abstract][Full Text] [Related]
11. Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients.
Körber N; Holzmann-Littig C; Wilkens G; Liao BH; Werz ML; Platen L; Cheng CC; Tellenbach M; Kappler V; Lehner V; Mijočević H; Christa C; Assfalg V; Heemann U; Schmaderer C; Protzer U; Braunisch MC; Bauer T; Renders L
Front Immunol; 2023; 14():1172477. PubMed ID: 37063863
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.
Benning L; Morath C; Bartenschlager M; Kim H; Reineke M; Beimler J; Buylaert M; Nusshag C; Kälble F; Reichel P; Töllner M; Schaier M; Klein K; Benes V; Rausch T; Rieger S; Stich M; Tönshoff B; Weidner N; Schnitzler P; Zeier M; Süsal C; Hien Tran T; Bartenschlager R; Speer C
Am J Transplant; 2022 Jul; 22(7):1873-1883. PubMed ID: 35384272
[TBL] [Abstract][Full Text] [Related]
13. Humoral and cellular immune response to SARS-CoV-2 mRNA BNT162b2 vaccine in pediatric kidney transplant recipients compared with dialysis patients and healthy children.
Gulmez R; Ozbey D; Agbas A; Aksu B; Yildiz N; Uckardes D; Saygili S; Yilmaz EK; Yildirim ZY; Tasdemir M; Kiykim A; Cokugras H; Canpolat N; Nayir A; Kocazeybek B; Caliskan S
Pediatr Nephrol; 2023 Jul; 38(7):2199-2208. PubMed ID: 36459243
[TBL] [Abstract][Full Text] [Related]
14. Immune response to third SARS-CoV-2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction.
Kantauskaite M; Müller L; Hillebrandt J; Lamberti J; Fischer S; Kolb T; Ivens K; Koch M; Andree M; Lübke N; Schmitz M; Luedde T; Orth HM; Feldt T; Schaal H; Adams O; Schmidt C; Kittel M; Königshausen E; Rump LC; Timm J; Stegbauer J
Clin Transplant; 2022 Nov; 36(11):e14790. PubMed ID: 35997031
[TBL] [Abstract][Full Text] [Related]
15. Determinants of Immune Response to Anti-SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients: A Prospective Cohort Study.
Magicova M; Zahradka I; Fialova M; Neskudla T; Gurka J; Modos I; Hojny M; Raska P; Smejkal P; Striz I; Viklicky O
Transplantation; 2022 Apr; 106(4):842-852. PubMed ID: 34999659
[TBL] [Abstract][Full Text] [Related]
16. Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients.
Kantauskaite M; Müller L; Kolb T; Fischer S; Hillebrandt J; Ivens K; Andree M; Luedde T; Orth HM; Adams O; Schaal H; Schmidt C; Königshausen E; Rump LC; Timm J; Stegbauer J
Am J Transplant; 2022 Feb; 22(2):634-639. PubMed ID: 34551181
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil-containing Immunosuppressive Regimens.
de Boer SE; Berger SP; van Leer-Buter CC; Kroesen BJ; van Baarle D; Sanders JF;
Transplantation; 2022 Aug; 106(8):1615-1621. PubMed ID: 35546527
[TBL] [Abstract][Full Text] [Related]
18. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
[TBL] [Abstract][Full Text] [Related]
19. Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants.
Chiu CH; Chang YH; Tao CW; Chang FY; Chiu KC; Chang TW; Yen LC
Microbiol Spectr; 2022 Oct; 10(5):e0060922. PubMed ID: 36005765
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients.
Ohki Y; Kawabe M; Yamamoto I; Katsumata H; Nakada Y; Kobayashi A; Urabe F; Miki J; Yamada H; Kimura T; Matsuo N; Tanno Y; Horino T; Ohkido I; Yamamoto H; Yokoo T
Front Microbiol; 2022; 13():922042. PubMed ID: 35756063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
